Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • X10-23 reagent improves the activity of DNAzymes!

New basalt rock found on the Pacific Ocean!

GEMys: Genetically Engineered Myeloid Cells Can stop the spread of Cancer?

X10-23 reagent improves the activity of DNAzymes!
  • BiotechToday
  • World

X10-23 reagent improves the activity of DNAzymes!

bioxone April 3, 2021April 3, 2021

Devyani Goswami, Amity University Kolkata

DNAzymes area type of DNA catalysts. DNAzymes are known for their specialty in catalyzing site-specific cleavage of any RNA substrate. RNA-cleaving DNA enzyme has a catalytic core and two short binding arms which form Watson and Crick base pairs with the RNA targets. RNA cleavage is possible with the assistance of Mg2+, Ca2+, Mn2+, Pb2+, or Zn2+as well as chemically modified DNA enzymes that can cleave RNAs in the absence of divalent metal ions.

DNA enzymes 10-23 are till now considered the modest content for any therapeutic procedure, for down-regulation of therapeutically relevant RNA targets. But the usage of DNAzymes has been halted due to their low efficiency in the clinical trials. To cope up with this problem, a xeno-nucleic acid-modified version of the 10-23 DNAzymes named X10-23, has been found that promises to resist nuclear digestion as well as achieve multiple turnover activity under cellular conditions.

X10-23, the new reagent claims to remove the issue of product inhibition by molecular chemo-types with DNA, 2′-fluoroarabino nucleic acid and α-L-threofuranosyl nucleic acid backbone structures that acknowledge balancing all the effects of biological stability with RNA hybridization along with divalent metal ion coordination. It was found that X10-23 facilitates gene silencing by degrading exogenous and endogenous mRNA transcripts efficiently in cultured mammalian cells. 

This technique claims to improve the stability and activity of DNAzymes. Although this technique still awaits clinical trial.

Also read: New basalt rock found on the Pacific Ocean!

REFERENCE: 1)A biologically stable DNAzyme that efficiently silences gene expression in cells https://www.nature.com/articles/s41557-021-00645-x

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged DNA DNA enzymes enzymes Gene gene silencing RNA RNA cleaving

2 thoughts on “X10-23 reagent improves the activity of DNAzymes!”

  1. Pingback: GEMys: Genetically Engineered Myeloid Cells Can stop the spread of Cancer? - BioXone
  2. Pingback: Scanning SWATH technology: Instant protein fingerprinting technique - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

GEMys: Genetically Engineered Myeloid Cells Can stop the spread of Cancer?

bioxone April 4, 2021

Koustav Maiti, Ramakrishna Mission Vivekananda Centenary College, Rahara Cancer can be defined by two properties: 1. They reproduce cells by the violation of normal cell growth and division, and 2. They occupy other regions conserved for other normal cells by the properties of invasion and metastasis. Metastasis is the most important character of cancer cells […]

GEMys

Related Post

  • BiotechToday
  • World

Antacid medication to help control diabetes

BioTech Today June 29, 2021June 28, 2021

Soumya Shraddhya Paul, Amity University Noida Diabetes has been a great area of concern for many people especially due to changing lifestyles as well as due to genetic reasons. Type 2 diabetes as of now affects 10% of the population worldwide and currently, the treatments which are prescribed by doctors involve lifestyle changes, insulin shot […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Heat Dome: The new outcome of global warming!

BioTech Today July 7, 2021July 6, 2021

Kiran Anup Budhrani, Chandigarh University What is El Nino and La Nina?  El Nino Southern Oscillation (ENSO) is a weather phenomenon generated due to the irregular variations in winds and surface temperature of the eastern pacific. Due to weak trade winds, the warm water gets accumulated on the Peruvian shore with warm water from Australia […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Corneal collagen cross-linking – a new way to treat keratoconus

BioTech Today July 26, 2021July 29, 2021

Shrestha Dutta, Amity University Kolkata Keratoconus is a continuous ectatic corneal disorder that gives rise to corneal stroma impedance and biomechanical weakening. Corneal collagen cross-connecting (CXL) is a powerful treatment to stop the growth of keratoconus. UV light of 3mW/cm2 is utilized in classic Dresden CXL for brightening and a single treatment technique needs 60 […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy